NEMESIS BIOSCIENCE LTD

📍 Cambridge, United Kingdom🗓 Founded 2014👥 1 employees💰 Last funded Dec 2021
Biotechnology🌐 nemesisbio.com
Website LinkedIn
Nemesis Bioscience is a biopharmaceutical company developing Nemesis Symbiotics© - DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens. These Nemesis Symbiotics© will make existing antibiotics work again, prevent the spread of resistance genes and so also protect the efficacy of new antibiotics. The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria. Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors and in vivo synthesis of biofuels and therapeutics. The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions. NEMESIS BIOSCIENCE LTD is a biotechnology company based on th Babraham Research Campus, Cambridge, CB22 3AT, UK
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in NEMESIS BIOSCIENCE LTD?
NEMESIS BIOSCIENCE LTD has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did NEMESIS BIOSCIENCE LTD last raise funding?
The most recent investment in NEMESIS BIOSCIENCE LTD recorded on gritt.io was in December 2021.
When was NEMESIS BIOSCIENCE LTD founded?
NEMESIS BIOSCIENCE LTD was founded in 2014.
What industry is NEMESIS BIOSCIENCE LTD in?
NEMESIS BIOSCIENCE LTD operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is NEMESIS BIOSCIENCE LTD based?
NEMESIS BIOSCIENCE LTD is headquartered in Cambridge, United Kingdom.